EAGLE BANCORP INC - COMMON STOCK (EGBN)

CUSIP: 268948106

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
+201,956
SEC-reported price per share
$57.01
Indexed holders
181
Value change
+$11,368,013
Number of buys
64
Number of sells
80
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
30,647,478

Security key

268948106

Report period

Q1 2022

Indexed institutions

181

Top holders

10

Ownership snapshot

Top reported holders of EGBN - EAGLE BANCORP INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $270,175,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $270.18M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $270.18M
VANGUARD GROUP INC $197.86M
WASATCH ADVISORS LP $139.97M
VICTORY CAPITAL MANAGEMENT INC $85.3M
DIMENSIONAL FUND ADVISORS LP $77.58M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$270,175,000
4,631,042 shares
— 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$197,863,000
3,391,540 shares
— 31 Dec 2021
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$139,974,000
2,399,279 shares
— 31 Dec 2021
VICTORY CAPITAL MANAGEMENT INC
13F
Company
13F
—
denominator unverified
$85,301,000
1,462,137 shares
— 31 Dec 2021
DIMENSIONAL FUND ADVISORS LP
13F
Company
13F
—
denominator unverified
$77,584,000
1,329,872 shares
— 31 Dec 2021
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$72,826,000
1,248,298 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
181
Shares
23,777,202
Indexed holders
181
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 indexed holders
181
Q1 2022 indexed holders
181
Indexed holder difference
0
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .